BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30450569)

  • 1. Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion via preventing the PI3K/AKT against STXBP5 expression in non-small-cell lung carcinoma.
    Huang J; Xie N; Huang H; Yao J; Hu W
    J Cell Biochem; 2019 May; 120(5):7489-7498. PubMed ID: 30450569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA STXBP5-AS1 inhibits cell proliferation, migration, and invasion through inhibiting the PI3K/AKT signaling pathway in gastric cancer cells.
    Cen D; Huang H; Yang L; Guo K; Zhang J
    Onco Targets Ther; 2019; 12():1929-1936. PubMed ID: 30881044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
    Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S
    Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA DDX11-AS1 promotes non-small cell lung cancer development via regulating PI3K/AKT signalling.
    Feng X; Yang S; Zhou S; Deng S; Xie Y
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1622-1631. PubMed ID: 32298476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant hypermethylation induced downregulation of antisense lncRNA STXBP5-AS1 and its sense gene STXBP5 correlate with tumorigenesis of glioma.
    Wang J; Yang L; Li Y; Wang XB; Yang W; Liu F; Wu XB
    Life Sci; 2021 Aug; 278():119590. PubMed ID: 33965377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive investigation of the prognostic values and molecular mechanisms of syntaxin binding protein 5 antisense RNA 1 in patients with colon adenocarcinoma based on RNA sequencing dataset.
    Wei H; Tang L; Wang J; Ni M; Liao X; Guo E
    J Cancer; 2023; 14(9):1607-1622. PubMed ID: 37325053
    [No Abstract]   [Full Text] [Related]  

  • 7. ROR1-AS1 knockdown inhibits growth and invasion and promotes apoptosis in NSCLC cells by suppression of the PI3K/Akt/mTOR pathway.
    Li F; Gu F; Li Q; Zhai C; Gong R; Zhu X
    J Biochem Mol Toxicol; 2021 May; 35(5):e22726. PubMed ID: 33491326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA STXBP5-AS1 suppresses stem cell-like properties of pancreatic cancer by epigenetically inhibiting neighboring androglobin gene expression.
    Chen S; Huang L; Li G; Qiu F; Wang Y; Yang C; Pan J; Wu Z; Chen J; Tian Y
    Clin Epigenetics; 2020 Nov; 12(1):168. PubMed ID: 33160411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1.
    Cheng G; Li Y; Liu Z; Song X
    Adv Clin Exp Med; 2021 Oct; 30(10):1043-1050. PubMed ID: 34610219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA
    Qu QH; Jiang SZ; Li XY
    Onco Targets Ther; 2020; 13():7949-7961. PubMed ID: 32884287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p.
    Chen T; Qin S; Gu Y; Pan H; Bian D
    Mol Genet Genomic Med; 2019 Aug; 7(8):e757. PubMed ID: 31207175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 14. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
    Cui F; Luo P; Bai Y; Meng J
    Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 stimulates lncRNA ZEB2-AS1 to aggravate the progression of non-small cell lung cancer through activating STAT1.
    Chen T; Li J; Zhou MH; Xu LJ; Pan TC
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3734-3740. PubMed ID: 32329850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Shao S; Wang C; Wang S; Zhang H; Zhang Y
    Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
    Wang A; Wang J
    DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.